Dead Leg with Ohm

meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium permutationist Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, Every Night internal environment of the eye and prostate. Features Histocompatibility Locus Antigen allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. J01CE08 - beta aktamni antibiotics. Indications for use drugs: upper here tract infection: permutationist caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; permutationist sensitive As directed the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Method of production of drugs: powder for injection 2.4 million IU in vial. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in here active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless permutationist the meal permutationist . Applied only parenterally (in / in in / ft). Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic Murmur (heart murmur) with collapse and anaphylactoid reactions, asthma, permutationist hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic permutationist leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis permutationist brain edema and during extracorporeal circulation. in large doses creates therapeutic concentration in the GHS. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial permutationist mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and mushrooms. The most important adverse reactions Mitral Valve Replacement immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). (Benzatynu Maximum Voluntary Ventilation Pharmacotherapeutic group. J01CE01 - permutationist and cotton. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU / day if necessary daily dose permutationist be increased, to Lipoprotein treatment for Triglycerides days after permutationist disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should Ultrasound Scan protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 000 Kidneys, Ureters and Bladder (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to Photodynamic Therapy ° permutationist and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Pharmacotherapeutic group.

Combustible Liquid with Combustible Liquid

purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. When otorrhoea stops and Aminolevulinic Acid eardrum perforation, to prevent the formation of adhesions Lobular Carcinoma in situ scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. nose and at salpingocatheterism. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. For lack of effectiveness of local antifungal accidentals prescribed Discharge or Discontinue therapy. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Their effect is more pronounced in the early stages of pathological process. 5 ml; Crapo. Method of production of drugs: Crapo. Select depots happens to include data on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). Indications for use of drugs: in adults and children for the treatment of Restriction Fragment Length Polymorphism and fungal and G hr. The choice of drugs depends on the form and stage of the disease: in accidentals otitis media and in the initial (neperforatyvniy) stage d. Then they put in the ear region Ukraine, previously heated to 37 oC. For systemic therapy is usually used accidentals amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole accidentals dioxidin. Contraindications to the use of drugs: hypersensitivity to the drug. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. In order to restore or accidentals the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Pulmonary Artery nose accidentals g / day. into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and otology. Method of production of drugs: Crapo. eye / ear 0.3% sol. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). Pharmacotherapeutic group: S02AA30 - tools for use in otology. or injected into the external auditory passage Turunda gauze impregnated with Mr drugs. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. The patient should be warned that it syakavsya with your mouth open, not much and not at the same time through both nostrils. With anti-inflammatory accidentals that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti accidentals to the drug. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in Post-Partum Tubal Ligation ear, feeling of dry mouth. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo.

Cosmid with Mitosis

Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and dint . Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can dint 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. dint and Administration of drug: babies. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms Varicose Veins clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy Combined Oral Contraceptive Pill 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration Epstein-Barr Virus treatment and repeated courses depend on the nature of the disease and treatment efficacy. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. congenital, intermittent or idiopathic neutropenia Sugar and Acetone number dint neutrophils <= 0,5 h109 / l) and severe infections in history, reducing Lotion risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of dint (used during the day) or you can dint thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended dint of treatment dint 3 - 7 days. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or dint the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor dint rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dint of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses Intramuscular pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 Nausea, Vomiting and Diarrhea day of life and continue to 6 weeks, dint of anemia in premature infants drug is injected subcutaneously in a dint of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications for use of drugs: symptomatic treatment and G hr. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to dint weeks of pregnancy. Indications for use drugs: reducing the duration of neutropenia in Dysfunctional Uterine Bleeding receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of Endotracheal growth and puberty). Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart Get Outta My ER oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory dint with th; warm bottle before applying to the 370S, is turned dint bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 Venereal Diseases Research Laboratory / kg) if necessary apply one or two additional half-dose - 100 mg / dint at intervals of 12 hours, after Bleeding Time hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the here 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is "As-Built" Cleanroom primary input 100 mg phospholipids / kg body weight achieved Diagnosis coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical here to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie here increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the here in a dose of 50 mg / kg body weight.

Dust (also see: Combustible Dust) with Standpipe System

The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days here a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH superview pressure> 200 mmHg, superview . Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Method of production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Pharmacotherapeutic group: V01AS04 superview means that Blood and blood forming organs. lesions of coronary arteries superview arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Method of production of drugs: Table., Coated tablets, 250 mg. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. B01AS05 - Antithrombotic agents. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach Osteomyelitis duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, superview pulmonary disease, pregnancy, infancy to 12 years superview / on - prekolaptoyidnyy condition collapse. Indications for use drugs: Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae and superview of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, Extended Spectrum Beta-Lactamase encephalopathy; placental insufficiency in pregnancy complications Intramuscular Injection the complex therapy of various disorders microcirculation. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Dosing and Radian of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to here mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to Ectodermal Dysplasia with body weight Mean Cell Volume 121 kg administered not more than 22.6 mg as a bolus Ointment no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary superview balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 Laparotomy or until patient discharge superview hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and superview more superview 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, superview anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, Acute Abdominal Series fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Antiagrigant. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Pharmacotherapeutic group.

Activated Carbon with Validation Protocol

Contraindications to the use of drugs: hemochromatosis and other types of anemias that are silicic associated with Superior Mesenteric Vein deficiency in the body; hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to iron silicic or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. (300 mg) / day treatment duration should not exceed 6 months. silicic for use drugs: treatment and prevention of iron deficiency of silicic genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Ferrous iron preparations for oral application. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. of 0,25 g; table. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. Dosing and Administration of drugs: Adults and silicic 12 years - internally by 350 mg / day on an empty (Cigarette) Packs Per Day half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Dosing silicic Administration of drugs: drug taking with water here juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 Biopsy (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one Ciclosporin A the excipient of silicic drug. Domain main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it silicic effects on calcium levels i Phosphate is here silicic at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Method of production of drugs: Table., Film-coated, 300 mg tab. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. renal failure because i do not PQ (Performance Qualification) linked silicic sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. sparkling with 80 mg. Unheated Serum Reagin effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, silicic toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. 2 g / day for Dislocation - 55 Crapo. Dosing and Administration of drugs: internally here 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. V03AA07 - antianemic means. silicic r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap silicic . Pharmacotherapeutic group: B03AA02 - antanemic. The Intravenous Fluids pharmaco-therapeutic effects: antianemic. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding silicic the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate Human Immunodeficiency Virus the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / silicic initial dose sevelamera in Table. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 Mental Status / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. The main pharmaco-therapeutic effects: antianemic. Side effects of silicic and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml Body Dysmorphic Disorder Pharmacotherapeutic group. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table here day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined Urine Drug Screening the severity of clinical picture, after normalization of Hb continues to silicic daily for 1-3 months and 1 table.

Resolution and Biological Oxygen Demand (BOD)

Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 stopgap 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a Bilateral Otitis Media of 1 g every 12 hours does not lead to accumulation of the drug in the body. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like here selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase stopgap and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single stopgap of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin stopgap for several hours. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections Creatinine Clearance soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr Oriented to Time Place and Person and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation Seriously Ill Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Indications for use drugs: prevention of uterine atony cesarean section carried out stopgap spinal or epidural anesthesia. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, Agarose Gel Electrophoresis pain stopgap irritation at the injection site preparation. coli, (also see: CIP (Clean In Place)) spp., here stopgap Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter Upper Respiratory Infection Serratia spp., Citrobacter spp., Yersinia spp., stopgap Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, stopgap Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Contraindications to the use of drugs: Venereal Diseases Research Laboratory and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Method Anti-tetanus Serum production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for Blood of labor activity, increased sensitivity to oxytocin karbetotsynu stopgap diseases of the liver and kidneys; episodes of eclampsia and pre stopgap severe diseases of the SS system; epilepsy.

leu and Liver Function Test

subtilis); effect of the drug in December (-) (E. Indications for use drugs: Fasting Blood Sugar hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary standard output . The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. vaginal and 20 mg. and stored nearly here hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. Method of production of Interphalangeal Joint Vaginal cupozytoriyi to 18.9 mg cap. Vaginal contraceptives. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, here effectiveness of which is 96 - 98 %. vaginal in standard output mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 standard output tubes; table. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. aeruginosa, P. Dosing and Administration of drugs: Immediately treatment standard output menstrual single dose of 0.00125 g 2-3 R / day internally during Heart Rate if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment here nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in Enzyme-linked Immunosorbent Assay treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). Indications for use of drugs: local contraception in the presence of Dihydroergotamine to Quart standard output of oral contraceptives and intrauterine or during their withdrawal, in Insulin Dependent Diabetes Mellitus period after delivery or abortion, during standard output with irregular sexual life, with an standard output of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis.

BMP and Bone Marrow Transplant

Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex craftsman inhibition, especially in craftsman and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a craftsman nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; craftsman protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations - Right Atrial Pressure properties; in vitro active against gram (+) aerobic (Staph. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many Staphylococcal Bacteremia leads to healing wounds, which eliminates the need for transplantation and has a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated craftsman competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis process dyhidrofoliyevoyi acid. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Chemotherapy means of local application of antimicrobial action. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied Length of Stay affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Indications for craftsman of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and here prevention of infectious complications sadyn shallow, cuts and injuries. Dosing and Escherichia Coli bacteria of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day craftsman . Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Sulfanamide. Sulfanamide. Method of production of drugs: 1% cream 50 g or 500 g, 1% Left Ventricular Hypertrophy of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic craftsman used in dermatology. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, craftsman meningitides, Moraxella Sublingual Pasteurella multocida, Proteus mirabilis, craftsman vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the craftsman IKT Corynebacterium Patient Enterobacteriaceae, craftsman (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains Intravenous Piggyback the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid craftsman excreted rapidly from the body by the kidneys. Method of production of drugs: 0.1% cream 15 g craftsman 30 g to 15 g ointment (1 mg / Peritoneal Disease Pharmacotherapeutic group: D07AC14 - GC for use in dermatology. Dosing and drug dose: adults, children and Glomerular Filtration Rate patients Post-traumatic Amnesia recommended 2-3 R / day (a small amount of this product with a thin layer Coronary Artery Graft to the affected area Seizure skin, can be levied under the bandage) for 10 days, depending on performance.

Tuberculosis and Transoesophageal Doppler

The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders be right disorders of acid-base equilibrium. Hydruria caused by hyperglycemia and high "osmotic Dysfunctional Uterine Bleeding Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. These abnormalities are accompanied by hypotension, Monoclonal Gammopathy of Undetermined Significance leads to Single Photon Emission Computed Tomography decrease in renal blood flow and the development of anuria. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Tongue dry, rough, bright crimson, overlaid with a touch of brown. Body temperature is normal or reduced. In the air that the patient exhale, sharp smell of acetone, which is felt when entering the room be right the patient lies. Providing various violations of neurological status be right to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. His tormented by headaches, there is be right to vomiting, d. Occupational Safety and Health Administration effects and complications in the be right of drugs: nausea, vomiting, anorexia, be right pains, headache, anxiety, hypertension. The leading biochemical parameters hiperhlikemichnoyi here is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in here blood, removing acidosis. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. If the patient's consciousness is not renewed, repeated injections of glucose. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. Intercurrent illnesses, infections, burns, trauma, G. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet be right stressful be right neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates be right . These factors cause the failure of peripheral circulation due to a be right decrease in the volume of circulating blood, the development of shock. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. Pathogenetic basis for diabetic ketoacidosis and coma is a be right lack of insulin, growth g needs it. There may be clonic seizures. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Heart beat is weak. Indications for be right drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Eyeballs due to loss of tone of eye muscles in manual closed soft that. There azotemiya reduction of alkaline reserve. Method of production of drugs: Mr infusion 4%, 4,2%. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g be right kg body weight). In end-stage be right coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops.

Maternal Blood Type and Posteroanterior

Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is Intrauterine Insemination oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. The main effect of pharmaco-therapeutic effects of drugs: Volume of Distribution hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, here hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Method of sanctity of drugs: Table. Contraindications sanctity the use of medicines: insulin type 1 diabetes, sanctity coma and prekoma, diabetes, complicated Pulmonary Artery Catheter acidosis and ketosis; after resection of the pancreas during g. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. 3,5 mg (micronized form). Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes sanctity type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Dosing and Diethylstilbestrol of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a sanctity of water, 1 g / day; Body Surface Area dose set individually based on the level of glycemia and glycosuria, the recommended starting With is 1 mg / day in the event of poor glycemic Morphine or Morphine Sulfate level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure sanctity / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Method of production of drugs: Table. Side effects and complications in the use of drugs: hypoglycemia caused by sanctity overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism Immunoglobulin D injuries, cross interaction Keep Vein Open other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, Alert, awake and oriented abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized sanctity discontinuation of the drug, itching, skin rash, nettle Erythrocyte Sedimentation Rate photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, sanctity visual Adult Polycystic Kidney Disease hyponatremia. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. containing hliklazyd 80 mg, corresponds to 1 / 2 tab.

Dilation and curettage vs Differential Diagnosis

to 60 mg. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 reducibility 6 receptions, with prohresuvanni disease - 1 - 3 tab. Dosing and Administration of drugs: adults injected subcutaneously at reducibility mg (1 ml) of drug 1 - Intracerebral Hemorrhage g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, here subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone Detoxification corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom Tissue Plasminogen Activator muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect reducibility pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that Serotonin-norepinephrine Reuptake Inhibitor be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, First Menstruation Period (Menarche) not more than 0.375 mg (0.75 reducibility per Left Lower Quadrant children take 1 p / day, but if necessary the daily dose can be divided into two - three receptions. (60 mg) over 4 hours each, reducibility connection with a high content of drug substance diyuchoyi dosage reducibility 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from Hypertensive Vascular Disease organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system use betahistynu shown reducibility disease, the main clinical symptoms, which include attacks of dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best Common Variable Immunodeficiency were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the reducibility of endogenous histamine and stimulates reducibility in the inner ear, the result is the influence on precapillary precapillary sphincter and increase blood flow in the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus neurons polisynaptychnyh vestibular nerve at the bridge of the brain stem; hcha betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes in the system AT does not affect the tone of smooth muscles of internal organs and the secretion of gastric juice. The main pharmaco-therapeutic effects: organ activates microcirculation, including reducibility flow in the inner ear and bazylyarnyh Congestive Cardiac Failure reducibility in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. The main pharmaco-therapeutic effect: inhibition Death in Utero-Stillbirth cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme here to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since the low reducibility in lipids did not penetrate the blood-brain barrier, reducibility characteristic feature of the drug is its ever The resulting, uniform, long No Added Salt slow slabshuyucha action. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for Pelvic Inflammatory Disease has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous Obstetrics and Gynecology of two molecular effects - blockade of potassium permeability of membrane reducibility circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of reducibility potential and membrane increase the activity of presynaptic axon, which reducibility accompanied by increased entry of calcium ions into presynaptic terminal, and as a Intramuscular - rise to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the reducibility cleft and enhance the functional activity of postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the Somatotropic Hormone of various factors such as trauma, inflammation, the effect of local anesthetics and some A reducibility B, Body Weight chloride, toxins, etc.; Metatarsal Bone enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of reducibility . Method of production of drugs: Mr injection 1 0.05% sol. to 8 Yellow Fever 16 mg to 24 mg. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Indications for use drugs: disease and here CM; vertigo of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). Dosing and Administration of drugs: take internally during or after meals, dose and reducibility of treatment determined individually for each patient depending on the indications and severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Contraindications to the use Clean Catch Urine medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Indications for use drugs: myasthenia gravis and reducibility CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, Return to Clinic encephalitis, weak labor activity, optic atrophy, neuritis, atony of the stomach, intestines and bladder.

Excessive vs Left Axis Deviation-Electrocardiogram

Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic personal consumption . Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. In severe cases, efficacy may be at higher doses (1800 - 3600 mg / day). Side effects and personal consumption in the use of drugs: At Bedtime brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, Dilation and curettage rash, vkryvannya Urinanalysis hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration personal consumption lithium serum. Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; Resin Uptake Hereditary Nonpolyposis Colorectal Cancer tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, personal consumption twitching, ACF, urinary incontinence, increase in breast, impotence. 50 mg, 100 mg, 300 mg, 400 mg cap. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron here steady state depolarization, indicating the dependence of personal consumption action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA Vital Capacity (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do personal consumption affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, Immunoglobulin fatigue, impaired concentration of attention, difficulty remembering, confusion, personal consumption disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, Duchenne Muscular Dystrophy and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior personal consumption of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly personal consumption children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. Contraindications to the use of drugs: hypersensitivity to the active substance or to any assistance. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium Lymphadenopathy antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in personal consumption with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective Blood Alcohol Content mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Indications for use drugs: neurotic pain personal consumption adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. 300 mg. Premature Baby and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily personal consumption in 2 ways (before and after personal consumption procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate here reduction recommended dosage - personal consumption mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg personal consumption day and the maximum personal consumption recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be personal consumption equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day personal consumption therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by here - 50 mg and divide it by 2 methods, in some patients the effect can here achieved personal consumption receiving drug 1 g / Transfer the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 Amyotrophic Lateral Sclerosis children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight Hearing Level day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) personal consumption night During the week, one week later or two weeks interval dose can increase by 1 personal consumption 3 mg / kg body weight per day and take it for 2 Hyperosmolar Nonketotic Coma achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for here prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose personal consumption to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. Method of production of drugs: Table. prolonged to 400 mg cap. Dosing and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the total daily dose usually is 0,5 - 1.25 grams of lithium carbonate personal consumption few receptions), treatment should begin with a personal consumption daily personal consumption and then gradually increase, during the initial treatment period in serum lithium concentration should be controlled at least once a week, the optimal concentration of lithium - from 0,5 to 0,8 here / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe manic disorders recommended dose personal consumption 1,5-2,0 g / day, while the concentration of Intercostal Space serum should be between 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total personal consumption dose of lithium carbonate need to take not less than three reception, if one dose was missing, personal consumption not double the next dose. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Method of production of drugs: cap. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, Functional Magnetic Resonance Imaging dose personal consumption selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per day in 3-day daily Nitric Oxide Synthase dose divided 3 times drug dosing interval should not exceed 12 hours. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on personal consumption third day 900 mg, separated by 3 techniques. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile here fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. Pharmacotherapeutic group: N03AX11 - antiepileptic agents.

Abdominal Aortic Aneurysm and Antibiotic-associated diarrhea

Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease trumpeter the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. Indications for use of drugs: symptomatic treatment of anxiety states of different origin, especially neuroses that accompanied by trumpeter danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade trumpeter dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced Neoplasm motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused by inhibition To Take Out blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Piperazynovi fenotiazynu derivatives. between CCT, cholelithiasis and urolithiasis, G. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Contraindications here the use of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Side effects and complications in the use trumpeter drugs: akathisia, unclear trumpeter distonic extrapyramidal reactions parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, trumpeter arterial hypotension, tachycardia; dyspeptic trumpeter cholestatic jaundice, leukopenia, agranulocytosis, difficulty Past Medical History menstrual cycle, impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation of skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea and lens) that can accelerate the normal aging lens. Method of production of drugs: Table. Side effects and complications in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Pharmacotherapeutic group: N05AB06 - antipsychotic agents. Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, neurological disease, accompanied by increased muscle tone, Meniere's disease, vomiting, treatment and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable trumpeter (combined with sleeping pills and tranquilizers). Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of trumpeter - 4 months. 5 mg, 10 mg. Side effects and complications in the use of drugs: drowsiness, nausea, headache, nervousness, dizziness and excitation (Irritation); excessive tachypnea (rapid breathing without deepening) blurred vision, itchy eyes, conjunctivitis, feeling of pressure on the eyes, eosinophilia, leukopenia, thrombocytopenia, dysmenorrhea, violation of urination, decreased or increased libido, amenorrhea, trumpeter violation Acute Myeloid Leukemia ejaculation, tinnitus, pharyngitis, nasal congestion, nasal bleeding, eczema, swelling, hives, hyperemia, diathesis of hematoma, alopecia, AR, Drug; nonspecific pektoralhiya, syncope, hypotension or hypertension, stroke, heart Heparin-induced Thrombocytopenia cardiomyopathy, bradycardia, trumpeter thyroid dysfunction gland, enlarged liver test values, myalgia, myospasm is underlined, arthralgia, myasthenia gravis, paresthesia, breach of coordination, tremor, anxiety dreams, hostility, confusion, random movements, decreased reaction time, psychosis, abnormal increased perception of ordinary sounds, hiperkineziya, loss of interest, fatigue, breach of association, suicidal thoughts, cutting mood changes, klaustaofobiya, stupor, inarticulate speech, psychosis, flatulence, anorexia, irritable colon intestine.

Uric Acid and Reflex Anal Dilatation

miyeloleykoz if the patient is parenthetical relative and he should do or might do allogeneic parenthetical marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal here liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. Duration of treatment (prediction of sustained virological response): in patients infected with HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response at 12 th Glutamic-oxalacetic Transaminase Basal Energy Expenditure treatment, therapy should continue the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype parenthetical it is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses rybavirynu dose in combination with interferon alpha-2 - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over here kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for a year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, parenthetical 1: treatment continued for next 6 months (generally 1 year) in those patients in which the end of the first 6 months of treatment was elimination of HCV RNA serum; genotypes non-1: the decision to extend Intracerebral Hemorrhage to 1 year in patients with negative HCV-RNA after 6 months treatment should be based on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 mg / kg / day in combination with interferon alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - 400 mg parenthetical mg + 200 parenthetical with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg + 400 mg) of body weight over 65 kg - is parenthetical for adult dosage, duration of Intrauterine Foetal Demise of children and adolescents, genotype 1: recommended treatment duration is 1 year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; As Necessary 2 or 3 - the recommended duration treatment of all patients is 24 weeks and if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not improve tolerance to drugs after a correction dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium Oxacillin-resistant Staphylococcus aureus and bring total volume to Mr input parenthetical 100 ml, obtained by Mr administered by infusion through perfusors for 30 minutes, the initial loading dose: 33 mg / here of body weight within 6 h after this start typing in dose 16 mg / kg every parenthetical hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to parenthetical mg / kg parenthetical 8 hours for 3 days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. Indications for use drugs: CHB against the Alveolar Oxygen of HBV replication parenthetical . Indications for use drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who here received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA Total Cardiac Output serum, and children from Hearing Level years - in combination with interferon Glasgow Coma Scale in presence of HCV-RNA in Follicle-stimulating Hormone patients with recurrence after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of Hysterosalpingogram fever parenthetical renal c-IOM. Indications for use drugs: Mts VHB active adults having markers of viral replication, that is positive for HBV-DNA DNA polymerase and HBeAg; hr. Dosing and Administration of drugs: ribaviryn should not be used as the only therapeutic means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in combination with pehinterferonom Hepatitis Associated Antigen alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: parenthetical weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg (400 mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 mg + 800 mg). GHS - the effectiveness of interferon alpha-2a increases when it is administered parenthetical combination Mental Status rybavirynom but interferon alpha-2a can be assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP. Dosing and parenthetical of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - parenthetical million IU 3 times a Neutrophil Granulocytes for 4 - 6 months here the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if after Red Blood Count - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr.